Clinical Trial Detail

NCT ID NCT02108782
Title Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications

pancreatic endocrine carcinoma

Therapies

Dovitinib

Age Groups: adult

No variant requirements are available.